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Longitudinal assessments highlight long-term
behavioural recovery in disorders of
consciousness
Corinne A. Bareham,1 Judith Allanson,2 Neil Roberts,3 Peter J. A. Hutchinson,1
John D. Pickard,1 David K. Menon4 and Srivas Chennu1,5
Accurate diagnosis and prognosis of disorders of consciousness is complicated by the variability amongst patients’ trajectories.
However, the majority of research and scientific knowledge in this field is based on cross-sectional studies. The translational gap in
applying this knowledge to inform clinical management can only be bridged by research that systematically examines follow-up. In
this study, we present findings from a novel longitudinal study of the long-term recovery trajectory of 39 patients, repeatedly
assessed using the Coma Recovery Scale-Revised once every 3months for 2 years, generating 185 assessments. Despite the expected
inter-patient variability, there was a statistically significant improvement in behaviour over time. Further, improvements began ap-
proximately 22months after injury. Individual variation in the trajectory of recovery was influenced by initial diagnosis. Patients
with an initial diagnosis of unresponsive wakefulness state, who progressed to the minimally conscious state, did so at a median of
485 days following onset—later than 12-month period after which current guidelines propose permanence. Although current guide-
lines are based on the expectation that patients with traumatic brain injury show potential for recovery over longer periods than
those with non-traumatic injury, we did not observe any differences between trajectories in these two subgroups. However, age
was a significant predictor, with younger patients showing more promising recovery. Also, progressive increases in arousal contrib-
uted exponentially to improvements in behavioural awareness, especially in minimally conscious patients. These findings highlight
the importance of indexing arousal when measuring awareness, and the potential for interventions to regulate arousal to aid long-
term behavioural recovery in disorders of consciousness.
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Introduction
The degree of variability amongst patients with prolonged
disorders of consciousness (pDOC) makes accurate diag-
nosis challenging (Royal College of Physicians, 2013).
Prognostication is similarly difficult, as patients are often
not followed up regularly. In large part, this is because
of fragmentation of care over the patient journey: they
are often transferred to specialist rehabilitation centres or
to the family home following acute care, with incomplete
records of their recovery history and outcomes.
Consequently, the majority of research in this field has
focused on cross-sectional research with convenience sam-
ples that do not inform on the natural history of recov-
ery. Moreover, the degree of variability surrounding
many existing prognostic indicators makes accurate prog-
nostication challenging. To this end, the pDOC practice
guidelines highlight the need for more systematic longitu-
dinal research to relate clinical presentation to outcomes
(Royal College of Physicians, 2013; Giacino et al., 2018).
To date, research using systematic behavioural assess-
ment has either followed patients for up to 12months
(Bagnato et al., 2017), or with relatively long gaps, e.g.
every 12months for 4 (Katz et al., 2009) or 5 years
(Luaute et al., 2010), or unevenly, e.g. at 1, 2 and
5 years post-injury (Nakase-Richardson et al., 2012).
Hence, this research has potentially missed when changes
in consciousness occur. This is particularly problematic
for unresponsive wakefulness state (UWS)/vegetative state
patients, as detecting and predicting recovery to minimal
consciousness (MCS) is important to inform treatment
plans. Current UK clinical guidelines propose UWS per-
manence following 12months with no change in con-
sciousness after traumatic brain injury (TBI), and
6months after non-traumatic injury (Royal College of
Physicians, 2013). However, some patients have shown
later recovery from UWS (Andrews, 1993; Childs and
Mercer, 1996; Strauss et al., 2000; Jennett, 2002; Faran
et al., 2006; Estraneo et al., 2010; Kuehlmeyer et al.,
2013; Estraneo et al., 2014; Steppacher et al., 2014). To
this end, the update to the clinical guidelines recommend
that diagnoses of permanence should no longer be made
in disorders of consciousness (DOC; Giacino et al.,
2018). These cases of late recovery highlight the challenge
clinicians face in providing an accurate prognosis.
Further, many reports reference symptom evolution in
these patients referenced to the time of admission to the
care facility, rather than the onset of the illness, limiting
generalizability (Giacino et al., 2018).
Patients’ presentation of behavioural responsiveness can
also change dramatically with fluctuations of arousal
(Wilson et al., 1996; Giacino et al., 2004; Wannez et al.,
2017). These fluctuations no doubt contribute to the high
(40%) rate of misdiagnosis of conscious awareness in
pDOC patients (Schnakers et al., 2009). Consciousness is
described as an interaction between arousal and aware-
ness (Laureys, 2005), and the Coma Recovery Scale-
Revised (CRS-R; Giacino et al., 2004) is considered the
most reliable and robust measure of consciousness for
pDOC (Bodien et al., 2016). Problematically, scores on
the CRS-R can change across a week (Giacino et al.,
2004; Wannez et al., 2017) or within a day (Candelieri
et al., 2011; Cortese et al., 2015) due to patient fluctua-
tions (Seel et al., 2010). Whilst changes in arousal sub-
scores naturally influence total CRS-R scores, the degree
to which arousal modulates CRS-R scores has yet to be
formally tested.
To address this gap in knowledge, we used the CRS-R
(Giacino et al., 2004; Bodien et al., 2016) in a systematic
longitudinal study to assess a group of patients at the
bedside every 3months across 2 years. Importantly, we
chose to include both DOC patients both early and late
stages of their behavioural trajectory. The first objective
of this novel study design was to characterize the natural
history of recovery, and emergence to higher states of
consciousness, to identify the important predictors of
CRS-R trajectories within and well beyond 12months.
Another objective was to investigate the effect of arousal
fluctuations on patients’ longitudinal CRS-R trajectories,
using the arousal subscale of the CRS-R. Importantly, we
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employed a valid systematic statistical approach [general
linear mixed model (GLMM)], to investigate effects
whilst controlling for other possible sources of variation
of patient trajectories, which also reduced multiple
testing.
Materials and methods
Ethics
This study was carried out in accordance with the recom-
mendations of the UK National Health Service Research
Ethics Committee for Cambridgeshire (reference: 16/EE/
0006). Patients’ next-of-kin gave written informed con-
sent or, in the absence of a suitable next-of-kin, the ward
manager acted as a nominated consultee and provided
written informed consent prior to enrolment in accord-
ance with the UK Mental Capacity Act 2005 and
Declaration of Helsinki.
Participants
Patients were recruited from and assessed at two special-
ist neurological rehabilitation centres, where they received
consistent and specialized care throughout the study.
Two patients resided at one centre and the other 37
resided at the other centre. To be recruited, patients
needed to be aged 16 years or older and clinically diag-
nosed with an apparent pDOC following any form of
sudden onset, non-progressive brain injury. Patients must
have been referred to or under review of a Consultant in
rehabilitation medicine or Consultant Neurologist.
Patients were excluded in the instance of pregnancy, if
they were clinically unstable or, if they were diagnosed
with a progressive neurological disease involving the
brain or a serious mental health condition prior to their
brain injury that has required active management by a
psychiatrist. Patients who emerged from a DOC during
or immediately prior to participation in the study were
also excluded.
Patients were assessed by neurologists throughout the
duration of the study. A convenience sample of 40
patients were recruited; however, one patient passed
away prior to the first scheduled assessment. The analy-
ses presented here are based on the remaining 39
patients. Of these, 16 had an initial CRS-R diagnosis of
UWS, 15 were MCS (minimally conscious minus; no
evidence of command following) and 7 MCSþ (minimally
conscious plus; evidence of command following) and 1
EMCS (emerged from a minimally conscious state).
Eighteen patients had an aetiology of TBI, with the
remaining 22 had an anoxic (14), stroke (5) or other (2)
injury. The patients (22 male, 17 female) were aged 19–
75 years (M¼ 42.85, SD ¼ 15.75) and were 174–
12,880 days post-ictus (M¼ 1018.64, SD ¼ 2056.77).
This sample of prolonged DOC patients allows for the
systematic assessment of the later history of recovery, be-
yond 12months post-injury, to identify predictors of
more longer-term outcomes for these patients. The num-
ber of patients declined across assessment number
(N¼ 39, 36, 29, 23, 19, 15, 13, 10 for Assessments 1–8,
respectively) due to attrition or late recruitment into the
study (see Fig. 1B). All time points cited in this article
are referenced to the date of ictus, rather than date of
admission to their care facility.
Design
The same researcher (C.A.B.) assessed the patients every
3months at the bedside using the CRS-R to determine
changes in behaviour. The researcher was formally
trained on CRS-R administration prior to commencement
of the study. Patients’ CRS-R diagnoses from the assess-
ments reported here were anecdotally corroborated by in-
dependent CRS-R assessments conducted by a
rehabilitation specialist (J.A.) as a part of clinical prac-
tice. The researcher was blind to these independent
assessments conducted by the specialist. In total, data
from 185 assessments (see Supplementary Table 1) from
the 39 patients were included in the analysis (see Fig. 1).
Coma Recovery Scale-Revised
The CRS-R is a 23-item scale behavioural assessment of
awareness for pDOC (Giacino et al., 2004). The scale is
split into subscales that measure the auditory, visual,
motor, oromotor/verbal, communication and arousal lev-
els of the patient. Some items are considered to be signs
of consciousness, with the most complex items indicating
EMCS. The CRS-R was administered by the same trained
neuropsychologist (C.A.B.) with each patient once at each
time point. If possible, the patient was assessed upright
in the chair. If this was not possible, patients were
assessed at the bedside with the bed elevated to an up-
right sitting position. When it was required, the arousal
intervention of applying deep pressure as per the CRS-R
guidelines was administered prior to and, if necessary,
throughout the duration of the examination to ensure the
patient achieved peak possible arousal during the
assessment.
Statistical analysis
All 185 behavioural and demographic measures collected
from patients and assessments were entered into a full
GLMM with a Poisson distribution (suitable for the dis-
crete, fixed CRS-R scale) and robust covariance (to ac-
count for outliers). A random factor of subject was
included to account for within-subject variability and the
different number of observations per subject. See Fig. 1C
for details of the model design. SPSS syntax was used to
fit the GLMM.
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Data availability
Data from the 185 assessments used in the presented
analysis is available in the Supplementary material.
Results
Longitudinal trajectories of Coma
Recovery Scale-Revised scores
There was a main effect of assessment number (F(7,132)
¼ 2.88, P < 0.01), highlighting that, overall, CRS-R
scores improved with assessment number (see Fig. 2A
and B). Pairwise contrasts (Bonferroni corrected) indi-
cated that whilst there was no difference among assess-
ments 1, 2 or 3, there was a significant change in CRS-R
from assessment 3 to 4 [t(132) ¼ 5.16, P < 0.001, con-
trast estimate (CE) ¼ 3.06], 5 to 6 [t(132) ¼ 3.18, P
¼ 0.03, CE ¼ 1.31], 6 to 7 [t(132) ¼ 4.727, P <
0.001, CE ¼ 2.48] and 7 to 8 [t(132) ¼ 10.93, P <
0.001, CE ¼ 4.78].
To verify the pattern of recovery remained in the 10
patients with all eight assessments, the model was fitted to
just that subgroup (Fig. 2C). The main effect of assessment
number remained with assessments 1–3 differing from
assessments 4–7 (all contrasts ¼ P < 0.05 Bonferroni
corrected).
Days since onset
The model indicated a significant main effect of days
since onset of injury—F(1,132) ¼ 15.20, P < 0.001)—
indicating that this was a significant predictor of CRS-R
scores. As Fig. 2B shows the upward shift in CRS-R
scores occurs after 663 days (approximately 22months)
since onset. This is in line with a meta-analysis of pDOC
case studies, which indicated that, in the natural history
of recovery, diagnosis can improve 22–25months post-in-
jury (Giacino et al., 2018). An interaction between assess-
ment number and days since onset—F(7,132) ¼ 4.21, P
¼ <0.001—indicated that days since the onset of injury
could explain the observed change in CRS-R scores over
time.
Figure 2D shows the proportion of patients with an
initial UWS diagnosis that recovered to a MCS (/þ)
diagnosis, as a function of median days since onset. Of
the 16 patients with an initial UWS diagnosis, 11
improved to MCS (68.75%) within the 2-year period of
assessments. The majority improved at assessment 2
(N¼ 6)—with three patients scoring a CRS-R diagnosis
of MCSþ—at a median of 485 days since injury. For
Figure 1 Longitudinal design of the project and the statistical model. (A) Illustration of the longitudinal design of the project. Patients
were assessed at the bedside every 3 months with the CRS-R. Data collection began in June 2016 and was completed in June 2018. Patients were
recruited at any point in the data collection period up until February 2018 to obtain a minimum of two assessments. (B) Figure illustrating, for
each patient, time elapsed since injury onset at the point of recruitment (left), alongside the timeline of individual assessments and CRS-R
diagnoses (right). Patients are ordered by time of recruitment into the study, and those recruited later had fewer assessments at the end of the 2-
year study period. (C) Table of the independent random and fixed factors included in the GLMM.
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patients with an initial MCS diagnosis (N¼ 15), only 6
(40%) showed an improvement to MCSþ that was main-
tained in subsequent assessments. For those that did
change, half (N¼ 3) showed this change at assessment
5—a median of 1167 days since onset. Two patients
improved to MCSþ before then, one at assessment 3 and
one at assessment 4 (median days since onset ¼ 992 and
1084, respectively), whilst the other showed improved
CRS-R diagnosis on assessment 6 (1152 days since onset).
These changes in CRS-R diagnosis occur much later for
patients with an initial MCS diagnosis than those with
an initial UWS diagnosis. One patient with an initial
MCS diagnosis who progressed to MCSþ went on to
EMCS on assessment 6 (1051 days since onset) evidenced
by functional and accurate communication. Two patients
with an initial MCSþ diagnosis progressed to EMCS,
one at assessment 2 (564 days since onset) and one at as-
sessment 3 (407 days post-ictus), evidence by functional
communication for one and functional object use for the
other.
Late recovery from unresponsive
wakefulness state to minimal
consciousness
To determine statistically whether our sample of UWS
patients showed evidence of late recovery (beyond the
12month period suggested to indicate permanence; Royal
College of Physicians, 2013), we ran the same GLMM
on just those patients with an initial UWS diagnosis
(N¼ 16 patients, 75 assessments) on only the data col-
lected after 12months post-ictus. Even in this subset of
data, there was a main effect of assessment number,
F(7,45) ¼ 17.80, P < 0.001, with significant
improvement in CRS-R scores seen at assessment 5
(assessments 1–4 differed from assessment 5, all P <
0.001 Bonferroni corrected) with a slight plateau in
scores from assessments 6–8 (only assessment 1 signifi-
cantly different from assessment 6, and assessments 1
and 2 differed from assessments 7 and 8 all P < 0.05
Bonferroni corrected). In sum, the analysis indicated im-
provement in CRS-R scores well beyond 12months (as-
sessment 1 median days post-ictus ¼ 646, range ¼ 409–
3251) with significant changes in behaviour at assessment
5 (median days post-ictus ¼ 764.5, range ¼ 566–3560).
In line with previous reports (Giacino and Kalmar,
1997; Bagnato et al., 2017), 10 of the 11 (91%) patients
who changed from UWS to MCS showed the first signs
of consciousness on the visual subscale. The other patient
(UWS to MCSþ) showed the first sign of consciousness
on the auditory scale with reproducible movement to
command (no evidence of visual pursuit). On the visual
subscale, consciousness was first evidenced with visual
fixation for two patients with the remaining eight show-
ing visual pursuit. One of the patients who progressed
from UWS to MCSþ directly went on to EMCS at
Assessment 5 (610 days since injury), as evidenced by
functional and accurate communication.
Initial Coma Recovery Scale-Revised
diagnosis
There was a main effect of initial CRS-R diagnosis (based
on the first assessment) on CRS-R scores (Fig. 3A):
F(2,132) ¼ 7.60, P < 0.01. Pairwise Bonferroni contrasts
indicated overall differences between patients diagnosed
as UWS and MCS [t(132) ¼ 4.41, P < 0.001, CE ¼
1.35] and UWS and MCSþ [t(132) ¼ 3.38, P <
Figure 2 Patients’ behavioural recovery over time. (A) Boxplots showing the CRS-R scores of the patients across assessment. Red lines
represent the medians and shaded areas represent the inter-quartile ranges. Individual scores are indicated as grey dots. (B) Illustration of the
mean CRS-R scores plotted against the median days since onset (three patients’ data were removed from this graph as observations were >2 
SDs above the group mean). Error bars represent the standard errors for the group. (C) Trajectory of mean CRS-R scores (black line) of a
subgroup of 10 patients who all had eight assessments. Standard error bars represent the standard error of the mean. Trajectories of individual
patients in the group are plotted as thin coloured lines. (D) Stacked bar chart showing the proportion of UWS patients that changed diagnosis
against the median days since injury onset at the time of the change.
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0.01, CE ¼ 2.15]. There was no statistical difference
between the MCS and MCSþ patients (see Fig. 4) and
no difference between any of the groups of patients and
the EMCS patient, likely due to a lack of statistical
power (N¼ 1 patient, four assessments). A two-way inter-
action between initial diagnosis and assessment number
(F(11,132) ¼ 9.89, P < 0.001) suggested that patients’
initial diagnoses played a significant part in their conse-
quent trajectory of recovery (see Fig. 3B), irrespective of
aetiology (Fig. 3C and D).
Age, gender and aetiology
Unlike previous literature (Jennett, 2002; Estraneo et al.,
2010), there was no main effect of aetiology on CRS-R
scores, and no two-way interaction between aetiology
and assessment number in our data (P > 0.05, see
Fig. 4A). Overall, 10 of the 18 TBI patients showed an
improvement in CRS-R diagnosis (55%). Similarly, 10 of
the 21 non-TBI patients (47%) also showed improvement
on CRS-R diagnosis across the 2-year period. It is pos-
sible that the non-significant effect of aetiology is due to
many of the assessments occurring at more chronic
stages, somewhat later than previous literature that has
shown aetiology as important to predict outcome. To in-
vestigate this, the interaction between aetiology and days
since onset was assessed. There was no significant inter-
action F(1,145) ¼ 0.80, P ¼ 0.37 between aetiology and
day since onset indicating that CRS-R scores were similar
between TBI and non-TBI subgroups regardless of the
Figure 3 Initial diagnosis as a predictor of recovery. (A) Boxplot of all 185 CRS-R scores collected from all patients, grouped by initial
diagnosis. Pairwise Bonferroni contrasts showed no difference between MCS patients but statistical differences between UWS and both the
MCS and MCSþ groups. (B) Mean CRS-R scores for patients grouped by initial diagnosis at each assessment. (C) Mean CRS-R scores at each
assessment for patients with a TBI aetiology grouped by initial diagnosis. (D) Mean CRS-R scores at each assessment for patients with a non-TBI
aetiology grouped by initial diagnosis. Standard error bars represent the standard errors of the means for all plots.
Figure 4 CRS-R scores grouped by aetiology and age. (A) Mean CRS-R scores for patients grouped by aetiology. Standard error bars
represent standard errors of the mean. (B) Illustration of trajectories for patients grouped by age. Younger patients, particularly those 20–
29 years show a more promising trajectory with higher CRS-R scores on later assessments than older patients. Standard error bars represent
standard errors of the mean.
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time since injury. Aetiology has been shown to predict
long-term outcome for UWS patients but not MCS
patients (Steppacher et al., 2014). In our sample of UWS
patients, there was no main effect of aetiology but there
was a significant interaction between aetiology and as-
sessment number, F(7,47) ¼ 17.78, P < 0.001; however,
the pairwise contrasts did not survive Bonferroni correc-
tion likely due to insufficient power. Although, it is
worth noting the two TBI patients initially in a UWS
state that recovered to a MCSþ, emerged within the first
12months post-ictus.
There was no main effect of age at first assessment
(P > 0.05) but there was a two-way interaction between
age and assessment number, F(7,132) ¼ 3.19, P <
0.001). Although patients start with similar CRS-R scores
(see Fig. 4B), younger patients—particularly those aged
20–29—show a more promising rate of recovery with
increases in CRS-R scores continuing onto later assess-
ments. Age as a covariate of recovery has also shown to
depend on initial diagnosis (Steppacher et al., 2014) with
age only having an effect on outcome for UWS patients.
In our sample of UWS patients, there was no main effect
of age but age did interact with assessment number,
F(7,54) ¼ 67.71, P < 0.001, consistent with previous
findings.
There was a main effect of gender—F(1,132) ¼ 9.09, P
< 0.01—with males (M¼ 10.28, SD ¼ 4.07) having a
higher CRS-R scores than females (9.48, SD ¼ 3.98)
overall t(132) ¼ 3.05, P < 0.01, CE ¼ 1.17.
However, there was no two-way interaction of gender by
assessment number (P > 0.05), indicating a similar trajec-
tory for both males and females.
Arousal
The arousal subscale of the CRS-R score was used as a
quasi-independent categorical measure of wakefulness. It
was expected that arousal scores would affect the other
subscale scores. In line with this, there was a main effect
of arousal [F(3,132) ¼ 188.79, P < 0.001], with all pos-
sible pairwise contrasts statistically significant (P < 0.001
Bonferroni corrected). Figure 5A shows that increases in
the arousal subscale led to greater CRS-R scores, above
and beyond the amount of increase in the arousal sub-
score itself.
There was also a two-way interaction between arousal
and assessment number, F(11,132) ¼ 2.86, P < 0.01,
across all patients indicating that CRS-R score trajectories
depend on arousal (all possible pairwise contrasts P <
0.01 Bonferroni corrected). For many patients, higher
Figure 5 Arousal as an important predictor of recovery. (A) Boxplots illustrating the total CRS-R scores and the subscale scores
associated with each categorical score on the arousal subscale. The plots demonstrate that higher scores on all the subscales typically occur at
highest arousal scores. (B) Example of an (initially) MCS patient that shows higher CRS-R scores at later assessments (6–8) that coincides with
higher scores on the arousal subscale. (C) Individual CRS-R score trajectories across assessments for each patient grouped by Initial diagnosis.
Individual patients’ trajectories are represented by different coloured lines. For most patients, there are clearly higher CRS-R scores when the
arousal subscale score is also higher. CRS-R scores are typically higher for later assessments and those later CRS-R scores are higher for patients
with an MCS or EMCS initial diagnosis.
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arousal scores coincided with higher CRS-R scores at
later assessments. As an exemplar, Fig. 5B shows an ex-
ample of an MCS patient who demonstrates a change
in the slope of CRS-R scores from assessments 1–4 to
assessments 5–8, reflecting a shift in CRS-R recovery
coinciding with increased arousal.
In patients with an initial diagnosis of UWS, there was
a significant interaction between arousal and assessment
number, F(4,57) ¼ 5.26, P < 0.01. CRS-R scores differed
significantly depending on the arousal scores for all assess-
ments except for assessments 2 and 6 (Bonferroni adjusted
P > 0.05). In patients with an initial MCS (/þ) diagno-
sis, there was again a significant interaction between
arousal and assessment number, F(10,82) ¼ 4.33, P <
0.001. For these patients, CRS-R score depended on
arousal at every assessment (P < 0.05 Bonferroni cor-
rected). Higher arousal scores seem to occur in later
assessments for the UWS and MCS groups (see
Fig. 5C). However, high arousal seems to occur at both
early and late assessments for the MCSþ group and the
single EMCS patient.
Discussion
Time since injury predicts recovery
Our findings from this longitudinal study have several
important clinical and ethical implications. Similar to re-
search of short-term outcomes (Whyte et al., 2009), time
since injury was an important predictor of CRS-R trajec-
tory across the 2-year period. Our cohort of prolonged
DOC patients began to show improvements in CRS-R
scores after assessment 3—22months post-onset. It is im-
portant to note that these signs of improvement are
somewhat later than many of those seen in studies of
other, less chronic, samples and might reflect the particu-
lar nature of our sample. Nonetheless, these late signs of
recovery have particular relevance for UWS. For the
UWS patients who improved to MCS, the median days
post-onset was 445 days—much later than the 12-month
timeline current guidelines propose for diagnosing UWS
permanence (Royal College of Physicians, 2013). This
finding adds to the weight of evidence from several stud-
ies demonstrating recovery beyond 12months post-onset
(Andrews, 1993; Childs and Mercer, 1996; Strauss et al.,
2000; Faran et al., 2006; Estraneo et al., 2010;
Kuehlmeyer et al., 2013; Estraneo et al., 2014;
Steppacher et al., 2014). A recent review reported cases
of UWS patients emerging to MCS or full recovery up to
6 years post-TBI (Kuehlmeyer et al., 2013). Together
these findings suggest that, in line with the recent update
to practice guidelines (Giacino et al., 2018), a diagnosis
of permanence, if made at all, should not be within the
first 24months post-ictus.
Inaccurate diagnosis of UWS permanence could lead to
patients prematurely being treated palliatively, focussing
on management rather than rehabilitation, leading to
poorer outcomes. Moreover, inaccurate diagnosis of UWS
permanence could lead to a nihilistic approach to care,
reducing potential for improvement (Kuehlmeyer et al.,
2013). The low expectation of recovery might bias family
decisions regarding life-sustaining treatment towards ter-
mination (Kuehlmeyer et al., 2013). These issues highlight
the importance of longitudinal research to arm clinicians
with more evidence to provide an accurate prognosis fol-
lowing severe brain injury. Conversely, the timeframe and
extent of recovery and influence of age can critically in-
form discussions with families, providing a framework
for best interests decisions taking into account patients’
age, comorbidities and individual choice.
The importance of diagnostic
accuracy
Rates of misdiagnosis in pDOC are recorded at approxi-
mately 40% (Schnakers et al., 2009). The substantial
range of complex comorbid difficulties and disorders
patients often present with, as well as variability in medi-
cations and available treatments, contributes to this diag-
nostic challenge. Problematically, the findings here
indicate that misdiagnosis could also lead to incorrect
prognostication. MCS patients showed a typically consist-
ent steady increase in CRS-R scores over time whilst
UWS patients showed an initial increase that plateaued
18months after injury. This plateau is likely due to high
attrition with those surviving having reached peak behav-
ioural responsiveness by this time. This finding is consist-
ent with research that shows a greater odd of recovery
for MCS patients (Giacino and Kalmar, 1997; Strauss
et al., 2000; Lammi et al., 2005; Voss et al., 2006;
Giacino et al., 2018).
The majority (4/5) of the UWS patients who did not
recover to MCS within 2 years had a non-traumatic aeti-
ology. This is consistent with the research that has found
that typically poorer outcomes for patients with a non-
traumatic injury (Giacino and Kalmar, 1997; Jennett,
2002; Giacino, 2004). Despite this, aetiology did not sig-
nificantly predict CRS-R score trajectories in this sample.
One possibility is that whilst aetiology may not be a sig-
nificant predictor of outcome for more chronic patients,
such as those reported here, it is still an important pre-
dictor of recovery in earlier stages post-injury. This could
explain the inconsistency of our findings to previous re-
search investigating predictors of recovery in less chronic
DOC patients. Although there was no significant inter-
action between aetiology and day since onset in our sam-
ple, it could be that the majority of the assessments here
occurred at much later stages post-injury, by which point
aetiology no longer has predictive power. Another possi-
bility is that the effect of aetiology is reduced due to the
inclusion of initial diagnosis as a factor in the model. In
line with previous literature (Steppacher et al., 2014),
aetiology did interact with assessment number on CRS-R
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scores for the UWS patients. The model also identified
age as an important predictor of CRS-R trajectories. This
finding is in concordance with the recent update to prac-
tice guidelines (Giacino et al., 2018), and previous re-
search has demonstrated that younger patients typically
have a better outcome (Braakman et al., 1988; Estraneo
et al., 2010).
First signs of consciousness
In line with previous research, progression from the UWS
to the MCS in our data was first seen with visual pur-
suit or fixation (Seel et al., 2010; Bagnato et al., 2017).
In patients that progressed to MCSþ, command follow-
ing was often evidenced with accurate object selection
using eye-related movements. Likewise, during progres-
sion to EMCS, the majority (3/4) evidenced awareness
via accurate communication—typically using eye blinks
or selecting ‘Yes/No’ using gaze. These observations are
not surprising, given these patients often have substantial
motor deficits, making progression on the motor function
scale somewhat challenging and unreliable. Further, vocal
responses are challenging for patients with tracheostomy.
Instead, movement of the eyes to communicate or demon-
strate awareness seems to be more achievable for patients
at all stages of recovery from severe brain injury.
The importance of arousal for
behavioural assessments of
consciousness
Our statistical analysis shows that arousal is an import-
ant factor contributing to CRS-R total scores. Increases
in the arousal subscale by just one point increased CRS-
R total scores exponentially, by engendering increases in
the other subscales. This validates the need for arousal
interventions, such as that in the CRS-R guidelines
(Giacino et al., 2004), to ensure the patient is at peak
possible arousal prior to administering behavioural assess-
ments of awareness. It is worth noting that not all behav-
ioural assessments include an arousal intervention (e.g.
the Wessex Head Injury Matrix; Shiel et al., 2000). The
findings here suggest that such measures might produce
an inaccurate representation of awareness state due to
lower than optimal arousal levels.
CRS-R trajectories depended on arousal scores at every
assessment with higher arousal scores associated with
higher CRS-R scores. For patients with an initial UWS
diagnosis, none demonstrated a level of arousal >2 even
after emerging to MCS. This could be because the in-
crease in CRS-R scores from an arousal score of 2–3 is
considerable, and might only be achieved by those with
an initial MCS diagnosis and a greater potential for re-
covery. For the MCS patients, those with high arousal
earlier had higher CRS-R scores on later assessments.
This is consistent with a report that indicated that the se-
quence of behavioural recovery began with arousal and
led onto more complex signs of cognition (Shiel et al.,
2000). Arousal then, may have some prognostic value,
predicting the likelihood of increases in overall behaviour-
al responsiveness over time.
Moreover, interventions to increase arousal could have
therapeutic benefits. Pharmacological approaches to in-
crease arousal levels, such as the use of zolpidem and
amantadine, have been shown to increase behavioural
awareness in pDOC patients (Whyte and Myers, 2009;
Giacino et al., 2012; Whyte et al., 2014). Further, the
use of electrical stimulation such as anodal transcranial
direct current stimulation (tDCS)—thought to increase
cortical excitability (Thibaut and Laureys, 2015)—has
shown to improve behavioural responsiveness in these
patients, particularly MCS (Thibaut et al., 2014; Thibaut
and Laureys, 2015; Thibaut et al., 2017). The effects of
tDCS have been considered to be the result of increased
frontal cortical excitability interacting with regions in the
brainstem, such as the striatum and thalamus, involved in
modulating arousal—an account called the mesocircuit
model (Thibaut and Laureys, 2015). In contrast, pharma-
cological interventions are thought to target brainstem
regions directly. Whether any of these stimulation meth-
ods have long-term benefits is yet to be formally assessed,
although one study showed some promise with repeated
assessments (N¼ 5) of anodal frontal tDCS showing
improvements in some MCS patients that lasted a week
later (Thibaut et al., 2017). Our findings suggest that
such methods to increase arousal should be included in
rehabilitation strategies to achieve better outcomes, par-
ticularly for MCS patients.
In addition, the powerful effect of arousal on behaviour
suggests that arousal is likely to have a similarly important
effect of neuroimaging assessments of awareness. Recent
advances in clinical neuroimaging have highlighted their
complementarity to behavioural assessments, with the po-
tential to improve diagnosis and prognosis. Arousal fluctua-
tions then, need to be factored in to the development of
neuroimaging tools for detecting awareness in pDOC.
Limitations
Previous research has shown that at least four CRS-R
assessments are required to achieve an accurate score/diag-
nosis (Wannez et al., 2017). Here, the CRS-R was adminis-
tered once every 3months, as multiple assessments at each
time point was not feasible, either due to time restrictions
or patient tolerance. Although the best care was taken to
ensure peak arousal, there is a possibility that the patient
trajectories presented here are nevertheless affected by
arousal fluctuations. To account for this, the arousal sub-
scale was included as a factor in the model, controlling for
such fluctuations as best as possible.
There are differing numbers of observations between
patients due to attrition and because patients were
recruited at any time point up until 3months before the
end of data collection. To account for this, a random
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factor of Subject was included in the model. Further, the
GLMM used a robust estimation method to account for
outliers in the main analyses. Nevertheless, given that
only one patient had an initial diagnosis of EMCS,
results that compare this patient to other subgroups
should be interpreted with caution.
All the patients in our sample resided in specialist
centres with access to rehabilitation services that patients
in other contexts may not have access to. Likewise, the
majority of patients were recruited from one neurological
centre. Further studies involving patients from multiple
centres are required to better characterize the role of the
rehabilitation context on patient trajectories.
Finally, an important limitation of this study was the
use of a single examiner who collected the CRS-R scores
reported here, and the consequent potential for undetect-
ed measurement error and potential variance. Although
the relatively modest scale of the study necessitated this,
future larger-scale studies might aim to employ multiple
examiners and establish inter-rater reliability of longitu-
dinal bedside measurements.
Conclusions
The longitudinal research project described here demon-
strates that pDOC patients do show long-term behaviour-
al improvements post-injury, extending over 2 years and
beyond. Whilst MCS patients show a more promising
and continuing trajectory of recovery, UWS patients
showed some initial improvement, and many do progress
to a MCS beyond 12months since injury. Our findings
have shown that several factors including initial diagnosis
and age need to be considered when making a clinical
prognosis. We have also shown that arousal variation is
an important predictor of trajectories. Moreover, these
arousal fluctuations have an important influence on the
behavioural assessment of consciousness at the bedside.
This highlights that, like the CRS-R, arousal interventions
should be included in the administration of systematic be-
havioural assessments. Arousal could also influence neu-
roimaging assessments of consciousness and arousal
interventions could have long-term therapeutic benefits.
Supplementary material
Supplementary material is available at Brain
Communications online.
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